Infos pratiques & communications

La pandémie de COVID-19 liée au coronavirus SARS-CoV-2 illustre combien les maladies infectieuses restent un enjeu de santé publique majeur à l’échelle mondiale. Elle rappelle également combien, face à une telle crise, l’exigence d’une recherche rigoureuse et de qualité est cruciale pour apporter des avancées ...

Le groupe de recherche sur les modifications post-traductionnelles bactériennes propose la première école thématique CNRS sur cette thématique en plein essor. Cette école aura lieu du 18/10/2021 au 22/10/2021 � ...

Article from the Global AMR R&D Hub newsletter, August 2021 edition One of the challenges inhibiting more unified and coordinated global action in the field of incentives for AMR produ ...

Published on Infectious Disease Special Edition

Published on Basilea.com on August 16, 2021. Basel, Switzerland, August 16, 2021 Basilea Pharmaceutica Ltd. ...

Join Vivli for a Foundation Briefing on Industry AMR Surveillance: Data for Action Featuring Remarks from:Dame Sally DaviesUK Special Envoy on Antimicrobial Resistance, UK Government; Master of Trinity College, Cambridge

Published on July 16, 2021 on the World Health Organization website Advisory ...

The Food and Drug Administration (FDA), Center for Biologics Evaluation and Research, and the National Institutes of Health, National Institute of Allergy and Infectious Diseases are announcing a public workshop entitled “Science and Regulation of Bacteriophage Therapy.” The purpose of the public workshop is to exchange ...

“Joining Forces” “Joining Forces” is the theme of AMRelay 2021. Joining forces to combat Antimicrobial resistance (AMR) as one of the biggest threats of health and food safety. Nothing more, nothing less. 

Less than a century after the discovery of penicillin, physicians are running out of options to treat bacterial infections. In fact, the next global pandemic could be caused by a multidrug resistant strain of a previously eradicated pathogen. New and sustainable novel sol ...